VivaZome Therapeutics is delighted to announce that our latest research has been published in Neurotrauma Reports.

This publication provides further evidence supporting the therapeutic potential of VivaZome’s proprietary extracellular vesicles to reduce damaging brain inflammation following a traumatic brain injury (TBI).

Brain inflammation after a TBI can persist long after the initial injury and can contribute to ongoing neurological damage and the development of post-traumatic epilepsy (PTE).

These findings provide important scientific support for VivaZome’s work to develop a new treatment approach that may help reduce harmful brain inflammation.

Our sincere thanks and congratulations to our team and collaborators, including Emeritus Prof. David Reutens, and his team, Dr Min Chen, Baani Bagga and Dr Stephen Edwards, and Vamshi Billakanti at The University of Queensland, whose expertise and contributions were instrumental to this important research.

This research was undertaken as part of the Australian Government’s Cooperative Research Centres Projects (CRC-P) Round 13 program, and we gratefully acknowledge the Government’s support.

Read the publication here:  https://doi.org/10.1177/2689288X261484016